NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

From the below video, it confirms the very heterogeneity nature of GBM which calls for truly personalized approach; no meaningful progresses have been made in treating GBM over the decades; CI as a class has seen successes in many indication in the past six to seven years, but shown no effects when it is used in treating GBM.

It's good thing there has been no mentioning of vaccine treatment for obvious reason, and while everyone involved look serious as the deadly GBM is the subject, FDA Pazdur is smiling all the time as if he were on drug and feels high.

Title and video:

Conquer and Cure GBM: A #GBMDay Panel Discussion - National Brain Tumor Society
826 views
Streamed live on Jul 21, 2021

Some excerpts from two participants:

Dr. Ned Sharpless
Director of the National Cancer Institute

"Doesn't look like progress at all until progress arrives, ......

my father died of metastatic melanoma in 2010. The first immunotherapy drug for metastatic melanin was approved in 2011. I can promise you in 2010 things looked pretty bleak for metastatic melanoma and that we has 30 years progress and lots of new therapies and lots of ideas but it didn't really pay off until about 12 months after my dad died so you know and now we cure cure big c make the cancer go away never come back most patients with metastatic melanoma now just a mere less than 10 years later

so when the progress happens it can happen pretty quickly it doesn't look much is happening from the outside until we get there pretty quickly ......

Dr. Richard Pazdur
Director of the FDA’s Oncology Center of Excellence

"So I think the drug regulation will follow after we have effective therapies and the regulatory hurdles to getting a drug approved will be minimal really if these drugs are truly effective..."

I don't know you, but I have been buying recently all the way down from $1.6s.